Ecp Tablets is primarily indicated in conditions like Contraception, Hormone replacement therapy, Menstruation disorders, Nausea and vomiting (chemotherapy induced), prevention.
Ecp Tablets is contraindicated in conditions like Migraine, Breast cancer, Hepatic disease, Circulatory system disease, Genital tract bleeding,Endometrial cancer,Lipid metabolism disorder.
The severe or irreversible adverse effects of Ecp Tablets, which give rise to further complications include Malignant hypertension. Ecp Tablets produces potentially life-threatening effects which include Venous thromboembolism, Ischemic heart disease, Cerebrovascular disease, Venous thromboembolism, Cerebrovascular disease. which are responsible for the discontinuation of Ecp Tablets therapy. The symptomatic adverse reactions produced by Ecp Tablets are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, vomiting, Anxiety, Weight gain, Breast tension, Depressive moods, Changes in libido, Menstrual irregularity, Abdominal discomfort, Uterine bleeding, dizziness, changes in libido.
Ecp Tablets should not be used during pregnancy or lactation. It should be used with caution in patients with any pre-existing liver disease, diabetes, seizure disorder, kidney disease, heart trouble, visual disorders, asthma or a history of depression, migraines, blood clots, miscarriage, breast cancer or any allergy.